Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
NBC News
—
Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients.
NBC News health reporter Aria Bendix explains what happens next.
Merck, Moderna melanoma vaccine succeeds
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial IOL —
- Merck, Moderna Melanoma Vaccine Study Succeeds Bloomberg —
- Merck, Moderna claim encouraging melanoma vaccine trial results South China Morning Post —
- Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning The New York Times —
- Merck, Moderna Stocks Soar After Melanoma Trial Success 📹 Bloomberg — · 2min